Last $0.02 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 12/16/14 All times are local (Market data is delayed by at least 15 minutes).

via pharmaceuticals inc (VIAP) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.02
52 Week High
01/31/14 - $0.05
52 Week Low
07/2/14 - $0.0053
Market Cap
308.4K
Average Volume 10 Days
3.8K
EPS TTM
$-0.46
Shares Outstanding
20.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VIA PHARMACEUTICALS INC (VIAP)

Related News

No related news articles were found.

via pharmaceuticals inc (VIAP) Related Businessweek News

No Related Businessweek News Found

via pharmaceuticals inc (VIAP) Details

VIA Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases. It is developing a pipeline of small molecule drugs that target the underlying causes of cardiovascular and metabolic diseases, including vascular inflammation, high cholesterol, high triglycerides, and insulin sensitization/diabetes. The company’s drug development pipeline includes VIA-3196, a Phase-1 ready liver-directed thyroid hormone receptor (THR) beta agonist that targets dyslipidemia, such as high LDL cholesterol, high triglycerides, and elevated Lp(a); Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor, which is in pre-clinical development stage treatment of type 2 diabetes with upside potential in weight control and dyslipidemia; and VIA-2291, a 5-Lipoxygenase inhibitor that has completed third Phase 2 clinical trial for the treatment of atherosclerotic plaque, an underlying cause of heart attack, stroke, and other vascular diseases. VIA Pharmaceuticals, Inc. has two research, development, and commercialization agreements with Hoffman-LaRoche Inc. and Hoffman-LaRoche Ltd. for THR beta agonist; and multiple compounds from preclinical DGAT1 metabolic disorders program. The company was founded in 2004 and is headquartered in San Francisco, California.

6 Employees
Last Reported Date: 03/24/11
Founded in 2004

via pharmaceuticals inc (VIAP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIAP:US $0.02 USD 0.00

VIAP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VIAP.
View Industry Companies
 

Industry Analysis

VIAP

Industry Average

Valuation VIAP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIA PHARMACEUTICALS INC, please visit www.viapharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.